N-cyclohexyl-6-(1,5-dimethyl-6-oxo-3-pyridinyl)imidazo[1,2-a]pyridine-3-sulfonamide;N-cyclopentyl-6-(1,5-dimethyl-6-oxo-3-pyridinyl)imidazo[1,2-a]pyridine-3-sulfonamide;5-[3-[(4,4-difluoropiperidin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-1,3-dimethylpyridin-2-one;6-(1,5-dimethyl-6-oxo-3-pyridinyl)-N-ethylimidazo[1,2-a]pyridine-3-sulfonamide;6-(1,5-dimethyl-6-oxo-3-pyridinyl)-N-propan-2-ylimidazo[1,2-a]pyridine-3-sulfonamide;1,3-dimethyl-5-(3-pyrrolidin-1-ylsulfonylimidazo[1,2-a]pyridin-6-yl)pyridin-2-one
C110H126F2N24O16S5 — CID 158130609
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-cyclohexyl-6-(1,5-dimethyl-6-oxo-3-pyridinyl)imidazo[1,2-a]pyridine-3-sulfonamide;N-cyclopentyl-6-(1,5-dimethyl-6-oxo-3-pyridinyl)imidazo[1,2-a]pyridine-3-sulfonamide;5-[3-[(4,4-difluoropiperidin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-1,3-dimethylpyridin-2-one;6-(1,5-dimethyl-6-oxo-3-pyridinyl)-N-ethylimidazo[1,2-a]pyridine-3-sulfonamide;6-(1,5-dimethyl-6-oxo-3-pyridinyl)-N-propan-2-ylimidazo[1,2-a]pyridine-3-sulfonamide;1,3-dimethyl-5-(3-pyrrolidin-1-ylsulfonylimidazo[1,2-a]pyridin-6-yl)pyridin-2-one
N-cyclohexyl-6-(1,5-dimethyl-6-oxo-3-pyridinyl)imidazo[1,2-a]pyridine-3-sulfonamide;N-cyclopentyl-6-(1,5-dimethyl-6-oxo-3-pyridinyl)imidazo[1,2-a]pyridine-3-sulfonamide;5-[3-[(4,4-difluoropiperidin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-1,3-dimethylpyridin-2-one;6-(1,5-dimethyl-6-oxo-3-pyridinyl)-N-ethylimidazo[1,2-a]pyridine-3-sulfonamide;6-(1,5-dimethyl-6-oxo-3-pyridinyl)-N-propan-2-ylimidazo[1,2-a]pyridine-3-sulfonamide;1,3-dimethyl-5-(3-pyrrolidin-1-ylsulfonylimidazo[1,2-a]pyridin-6-yl)pyridin-2-one (PubChem CID 158130609) has the molecular formula C110H126F2N24O16S5 and a molecular weight of 2238.70 g/mol. Its IUPAC name is N-cyclohexyl-6-(1,5-dimethyl-6-oxo-3-pyridinyl)imidazo[1,2-a]pyridine-3-sulfonamide;N-cyclopentyl-6-(1,5-dimethyl-6-oxo-3-pyridinyl)imidazo[1,2-a]pyridine-3-sulfonamide;5-[3-[(4,4-difluoropiperidin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-1,3-dimethylpyridin-2-one;6-(1,5-dimethyl-6-oxo-3-pyridinyl)-N-ethylimidazo[1,2-a]pyridine-3-sulfonamide;6-(1,5-dimethyl-6-oxo-3-pyridinyl)-N-propan-2-ylimidazo[1,2-a]pyridine-3-sulfonamide;1,3-dimethyl-5-(3-pyrrolidin-1-ylsulfonylimidazo[1,2-a]pyridin-6-yl)pyridin-2-one.
Molecular Properties
| Compound Name | N-cyclohexyl-6-(1,5-dimethyl-6-oxo-3-pyridinyl)imidazo[1,2-a]pyridine-3-sulfonamide;N-cyclopentyl-6-(1,5-dimethyl-6-oxo-3-pyridinyl)imidazo[1,2-a]pyridine-3-sulfonamide;5-[3-[(4,4-difluoropiperidin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-1,3-dimethylpyridin-2-one;6-(1,5-dimethyl-6-oxo-3-pyridinyl)-N-ethylimidazo[1,2-a]pyridine-3-sulfonamide;6-(1,5-dimethyl-6-oxo-3-pyridinyl)-N-propan-2-ylimidazo[1,2-a]pyridine-3-sulfonamide;1,3-dimethyl-5-(3-pyrrolidin-1-ylsulfonylimidazo[1,2-a]pyridin-6-yl)pyridin-2-one |
|---|---|
| PubChem CID | 158130609 |
| Molecular Formula | C110H126F2N24O16S5 |
| Molecular Weight | 2238.70 g/mol |
| Exact Mass | 2236.84 |
| IUPAC Name | N-cyclohexyl-6-(1,5-dimethyl-6-oxo-3-pyridinyl)imidazo[1,2-a]pyridine-3-sulfonamide;N-cyclopentyl-6-(1,5-dimethyl-6-oxo-3-pyridinyl)imidazo[1,2-a]pyridine-3-sulfonamide;5-[3-[(4,4-difluoropiperidin-1-yl)methyl]imidazo[1,2-a]pyridin-6-yl]-1,3-dimethylpyridin-2-one;6-(1,5-dimethyl-6-oxo-3-pyridinyl)-N-ethylimidazo[1,2-a]pyridine-3-sulfonamide;6-(1,5-dimethyl-6-oxo-3-pyridinyl)-N-propan-2-ylimidazo[1,2-a]pyridine-3-sulfonamide;1,3-dimethyl-5-(3-pyrrolidin-1-ylsulfonylimidazo[1,2-a]pyridin-6-yl)pyridin-2-one |
| SMILES | CCNS(=O)(=O)c1cnc2ccc(-c3cc(C)c(=O)n(C)c3)cn12.Cc1cc(-c2ccc3ncc(CN4CCC(F)(F)CC4)n3c2)cn(C)c1=O.Cc1cc(-c2ccc3ncc(S(=O)(=O)N4CCCC4)n3c2)cn(C)c1=O.Cc1cc(-c2ccc3ncc(S(=O)(=O)NC(C)C)n3c2)cn(C)c1=O.Cc1cc(-c2ccc3ncc(S(=O)(=O)NC4CCCC4)n3c2)cn(C)c1=O.Cc1cc(-c2ccc3ncc(S(=O)(=O)NC4CCCCC4)n3c2)cn(C)c1=O |
| InChI | InChI=1S/C20H22F2N4O.C20H24N4O3S.C19H22N4O3S.C18H20N4O3S.C17H20N4O3S.C16H18N4O3S/c1-14-9-16(11-24(2)19(14)27)15-3-4-18-23-10-17(26(18)12-15)13-25-7-5-20(21,22)6-8-25;1-14-10-16(12-23(2)20(14)25)15-8-9-18-21-11-19(24(18)13-15)28(26,27)22-17-6-4-3-5-7-17;1-13-9-15(11-22(2)19(13)24)14-7-8-17-20-10-18(23(17)12-14)27(25,26)21-16-5-3-4-6-16;1-13-9-15(11-20(2)18(13)23)14-5-6-16-19-10-17(22(16)12-14)26(24,25)21-7-3-4-8-21;1-11(2)19-25(23,24)16-8-18-15-6-5-13(10-21(15)16)14-7-12(3)17(22)20(4)9-14;1-4-18-24(22,23)15-8-17-14-6-5-12(10-20(14)15)13-7-11(2)16(21)19(3)9-13/h3-4,9-12H,5-8,13H2,1-2H3;8-13,17,22H,3-7H2,1-2H3;7-12,16,21H,3-6H2,1-2H3;5-6,9-12H,3-4,7-8H2,1-2H3;5-11,19H,1-4H3;5-10,18H,4H2,1-3H3 |
| InChIKey | FSSOSRPIRUXDEW-UHFFFAOYSA-N |
| XLogP | 12.88 |
| TPSA | 461.10 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 35 |
| Rotatable Bonds | 22 |
| Heavy Atoms | 157 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2238.70 |
| LogP ≤ 5 | 12.88 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 35 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158130609 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.